Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 184 (2), 383-388
- https://doi.org/10.1016/j.atherosclerosis.2005.05.002
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial InfarctionNew England Journal of Medicine, 2004
- Asymmetrical dimethylarginine: A novel risk factor for coronary artery diseaseClinical Cardiology, 2003
- Endothelial Dysfunction Induced by Hyperhomocyst(e)inemiaCirculation, 2003
- Homocysteine Impairs the Nitric Oxide Synthase PathwayCirculation, 2001
- An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytesJournal of the American College of Cardiology, 2000
- Biological significance of endogenous methylarginines that inhibit nitric oxide synthasesCardiovascular Research, 1999
- Novel Mechanism for Endothelial DysfunctionCirculation, 1999
- Hyperhomocyst(e)inemia Is Associated With Impaired Endothelium-Dependent Vasodilation in HumansCirculation, 1997
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992